Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease

Authors: Jin Ho Hwang, Hayne Cho Park, Jong Cheol Jeong, Seon ha Baek, Mi Yeun Han, Kitae Bang, Jeong Yeon Cho, Suk Hee Yu, Jaeseok Yang, Kook-Hwan Oh, Young-Hwan Hwang, Curie Ahn

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Urinary tract infection (UTI) occurs in 30%-50% of individuals with autosomal dominant polycystic kidney disease (ADPKD). However, the clinical relevance of asymptomatic pyuria in ADPKD patients remains unknown.

Methods

We retrospectively reviewed medical records of 256 ADPKD patients who registered to the ADPKD clinic at Seoul National University Hospital from Aug 1999 to Aug 2010. We defined the asymptomatic pyuria as more than 5-9 white blood cells in high-power field with no related symptoms or signs of overt UTI. Patients were categorized into 2 groups depending on its duration and frequency: Group A included non-pyuria and transient pyuria patients; Group B included recurrent and persistent pyuria patients. The association between asymptomatic pyuria and both the development of overt UTI and the deterioration of renal function were examined.

Results

With a mean follow-up duration of 65.3 months, 176 (68.8%) out of 256 patients experienced 681 episodes of asymptomatic pyuria and 50 episodes of UTI. The annual incidence of asymptomatic pyuria was 0.492 episodes/patient/year. The patients in group B showed female predominance (58.5% vs. 42.0%, P=0.01) and experienced an upper UTI more frequently (hazard ratio: 4.612, 95% confidence interval: 1.735-12.258; P=0.002, adjusted for gender and hypertension). The annual change in estimated glomerular filtration rate (ΔeGFR) was significantly larger in magnitude in group B than in group A (-2.7±4.56 vs. -1.17±5.8, respectively; P=0.01). Age and Group B found to be the independent variables for ΔeGFR and developing end-stage renal disease (16.0% vs. 4.3%, respectively; P=0.001).

Conclusions

Chronic asymptomatic pyuria may increase the risk of developing overt UTI and may contribute to declining renal function in ADPKD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Igarashi P, Somlo S: Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2002, 13 (9): 2384-2398. 10.1097/01.ASN.0000028643.17901.42.CrossRefPubMed Igarashi P, Somlo S: Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol. 2002, 13 (9): 2384-2398. 10.1097/01.ASN.0000028643.17901.42.CrossRefPubMed
2.
go back to reference Brenner FCR, Barry M: Brenner & Rector’s The Kidney. 2000, Philadelphia, PA: WB Saunders Company, 6th Brenner FCR, Barry M: Brenner & Rector’s The Kidney. 2000, Philadelphia, PA: WB Saunders Company, 6th
3.
go back to reference Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA: Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. 2001, 59 (5): 1654-1662. 10.1046/j.1523-1755.2001.0590051654.x.CrossRefPubMed Fick-Brosnahan GM, Tran ZV, Johnson AM, Strain JD, Gabow PA: Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int. 2001, 59 (5): 1654-1662. 10.1046/j.1523-1755.2001.0590051654.x.CrossRefPubMed
4.
go back to reference Koslowe O, Frank R, Gauthier B, Vergara M, Trachtman H: Urinary tract infections, VUR, and autosomal dominant polycystic kidney disease. Pediatr Nephrol. 2003, 18 (8): 823-825. 10.1007/s00467-003-1211-4.CrossRefPubMed Koslowe O, Frank R, Gauthier B, Vergara M, Trachtman H: Urinary tract infections, VUR, and autosomal dominant polycystic kidney disease. Pediatr Nephrol. 2003, 18 (8): 823-825. 10.1007/s00467-003-1211-4.CrossRefPubMed
5.
go back to reference Sklar AH, Caruana RJ, Lammers JE, Strauser GD: Renal infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1987, 10 (2): 81-88.CrossRefPubMed Sklar AH, Caruana RJ, Lammers JE, Strauser GD: Renal infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1987, 10 (2): 81-88.CrossRefPubMed
6.
go back to reference Schwab SJ, Bander SJ, Klahr S: Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987, 82 (4): 714-718. 10.1016/0002-9343(87)90005-2.CrossRefPubMed Schwab SJ, Bander SJ, Klahr S: Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987, 82 (4): 714-718. 10.1016/0002-9343(87)90005-2.CrossRefPubMed
7.
go back to reference Chow CL, Ong AC: Autosomal dominant polycystic kidney disease. Clin Med. 2009, 9 (3): 278-283.CrossRef Chow CL, Ong AC: Autosomal dominant polycystic kidney disease. Clin Med. 2009, 9 (3): 278-283.CrossRef
8.
go back to reference Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992, 41 (5): 1311-1319. 10.1038/ki.1992.195.CrossRefPubMed Gabow PA, Johnson AM, Kaehny WD, Kimberling WJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Kidney Int. 1992, 41 (5): 1311-1319. 10.1038/ki.1992.195.CrossRefPubMed
9.
go back to reference Ahmed ER, Tashkandi MA, Nahrir S, Maulana A: Retrospective analysis of factors affecting the progression of chronic renal failure in adult polycystic kidney disease. Saudi J Kidney Dis Transpl. 2006, 17 (4): 511-515.PubMed Ahmed ER, Tashkandi MA, Nahrir S, Maulana A: Retrospective analysis of factors affecting the progression of chronic renal failure in adult polycystic kidney disease. Saudi J Kidney Dis Transpl. 2006, 17 (4): 511-515.PubMed
10.
go back to reference Idrizi A, Barbullushi M, Petrela E, Kodra S, Koroshi A, Thereska N: The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease. Hippokratia. 2009, 13 (3): 161-164.PubMedPubMedCentral Idrizi A, Barbullushi M, Petrela E, Kodra S, Koroshi A, Thereska N: The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease. Hippokratia. 2009, 13 (3): 161-164.PubMedPubMedCentral
11.
go back to reference Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, et al: Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009, 20 (1): 205-212. 10.1681/ASN.2008050507.CrossRefPubMedPubMedCentral Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, et al: Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009, 20 (1): 205-212. 10.1681/ASN.2008050507.CrossRefPubMedPubMedCentral
12.
go back to reference Ramakrishnan K, Scheid DC: Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician. 2005, 71 (5): 933-942.PubMed Ramakrishnan K, Scheid DC: Diagnosis and management of acute pyelonephritis in adults. Am Fam Physician. 2005, 71 (5): 933-942.PubMed
13.
go back to reference Sallee M, Rafat C, Zahar JR, Paulmier B, Grunfeld JP, Knebelmann B, Fakhouri F: Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (7): 1183-1189. 10.2215/CJN.01870309.CrossRefPubMedPubMedCentral Sallee M, Rafat C, Zahar JR, Paulmier B, Grunfeld JP, Knebelmann B, Fakhouri F: Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009, 4 (7): 1183-1189. 10.2215/CJN.01870309.CrossRefPubMedPubMedCentral
14.
go back to reference Greg Miller W, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, Siekmann L: Creatinine Measurement: State of the Art in Accuracy and Interlaboratory Harmonization. Archives of Pathology & Laboratory Medicine. 2005, 129 (3): 297-304. Greg Miller W, Myers GL, Ashwood ER, Killeen AA, Wang E, Thienpont LM, Siekmann L: Creatinine Measurement: State of the Art in Accuracy and Interlaboratory Harmonization. Archives of Pathology & Laboratory Medicine. 2005, 129 (3): 297-304.
15.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al: A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150 (9): 604-612.CrossRefPubMedPubMedCentral
16.
go back to reference Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, et al: Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010, 56 (3): 486-495. 10.1053/j.ajkd.2010.03.026.CrossRefPubMedPubMedCentral Stevens LA, Schmid CH, Greene T, Zhang YL, Beck GJ, Froissart M, Hamm LL, Lewis JB, Mauer M, Navis GJ, et al: Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis. 2010, 56 (3): 486-495. 10.1053/j.ajkd.2010.03.026.CrossRefPubMedPubMedCentral
17.
go back to reference K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): 1-266. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39 (2 Suppl 1): 1-266.
18.
go back to reference Meadow SR, White RH, Johnston NM: Prevalence of symptomless urinary tract disease in Birmingham schoolchildren. I. Pyuria and bacteriuria. British medical journal. 1969, 3 (5662): 81-84.CrossRefPubMed Meadow SR, White RH, Johnston NM: Prevalence of symptomless urinary tract disease in Birmingham schoolchildren. I. Pyuria and bacteriuria. British medical journal. 1969, 3 (5662): 81-84.CrossRefPubMed
19.
go back to reference Ozdem S, Bayraktar T, Oktay C, Sari R, Gultekin M: The prevalence of asymptomatic pyuria in diabetic patients: comparison of the Sysmex UF-100 automated urinalysis analyzer with Fuchs-Rosenthal hemacytometer. Clin Biochem. 2006, 39 (9): 873-878. 10.1016/j.clinbiochem.2006.06.007.CrossRefPubMed Ozdem S, Bayraktar T, Oktay C, Sari R, Gultekin M: The prevalence of asymptomatic pyuria in diabetic patients: comparison of the Sysmex UF-100 automated urinalysis analyzer with Fuchs-Rosenthal hemacytometer. Clin Biochem. 2006, 39 (9): 873-878. 10.1016/j.clinbiochem.2006.06.007.CrossRefPubMed
20.
21.
go back to reference Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG: A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med. 2007, 13 (12): 1490-1495. 10.1038/nm1675.CrossRefPubMedPubMedCentral Piontek K, Menezes LF, Garcia-Gonzalez MA, Huso DL, Germino GG: A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med. 2007, 13 (12): 1490-1495. 10.1038/nm1675.CrossRefPubMedPubMedCentral
22.
go back to reference Lantinga-van Leeuwen IS, Leonhard WN, van der Wal A, Breuning MH, de Heer E, Peters DJ: Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum Mol Genet. 2007, 16 (24): 3188-3196. 10.1093/hmg/ddm299.CrossRefPubMed Lantinga-van Leeuwen IS, Leonhard WN, van der Wal A, Breuning MH, de Heer E, Peters DJ: Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum Mol Genet. 2007, 16 (24): 3188-3196. 10.1093/hmg/ddm299.CrossRefPubMed
23.
go back to reference Takakura A, Contrino L, Beck AW, Zhou J: Pkd1 inactivation induced in adulthood produces focal cystic disease. J Am Soc Nephrol. 2008, 19 (12): 2351-2363. 10.1681/ASN.2007101139.CrossRefPubMedPubMedCentral Takakura A, Contrino L, Beck AW, Zhou J: Pkd1 inactivation induced in adulthood produces focal cystic disease. J Am Soc Nephrol. 2008, 19 (12): 2351-2363. 10.1681/ASN.2007101139.CrossRefPubMedPubMedCentral
24.
go back to reference Grantham JJ: Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008, 359 (14): 1477-1485.PubMed Grantham JJ: Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008, 359 (14): 1477-1485.PubMed
25.
go back to reference Bastos AP, Piontek K, Silva AM, Martini D, Menezes LF, Fonseca JM, Fonseca II, Germino GG, Onuchic LF: Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion. J Am Soc Nephrol. 2009, 20 (11): 2389-2402. 10.1681/ASN.2008040435.CrossRefPubMedPubMedCentral Bastos AP, Piontek K, Silva AM, Martini D, Menezes LF, Fonseca JM, Fonseca II, Germino GG, Onuchic LF: Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion. J Am Soc Nephrol. 2009, 20 (11): 2389-2402. 10.1681/ASN.2008040435.CrossRefPubMedPubMedCentral
26.
go back to reference Happe H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E, Peters DJ: Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet. 2009, 18 (14): 2532-2542. 10.1093/hmg/ddp190.CrossRefPubMed Happe H, Leonhard WN, van der Wal A, van de Water B, Lantinga-van Leeuwen IS, Breuning MH, de Heer E, Peters DJ: Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways. Hum Mol Genet. 2009, 18 (14): 2532-2542. 10.1093/hmg/ddp190.CrossRefPubMed
27.
go back to reference Takakura A, Contrino L, Zhou X, Bonventre JV, Sun Y, Humphreys BD, Zhou J: Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet. 2009, 18 (14): 2523-2531. 10.1093/hmg/ddp147.CrossRefPubMedPubMedCentral Takakura A, Contrino L, Zhou X, Bonventre JV, Sun Y, Humphreys BD, Zhou J: Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet. 2009, 18 (14): 2523-2531. 10.1093/hmg/ddp147.CrossRefPubMedPubMedCentral
28.
go back to reference Arnaout MA: Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease. Annu Rev Med. 2001, 52: 93-123. 10.1146/annurev.med.52.1.93.CrossRefPubMed Arnaout MA: Molecular genetics and pathogenesis of autosomal dominant polycystic kidney disease. Annu Rev Med. 2001, 52: 93-123. 10.1146/annurev.med.52.1.93.CrossRefPubMed
29.
go back to reference Weimbs T: Third-hit signaling in renal cyst formation. J Am Soc Nephrol. 2011, 22 (5): 793-795. 10.1681/ASN.2011030284.CrossRefPubMed Weimbs T: Third-hit signaling in renal cyst formation. J Am Soc Nephrol. 2011, 22 (5): 793-795. 10.1681/ASN.2011030284.CrossRefPubMed
30.
go back to reference Gardner KD, Reed WP, Evan AP, Zedalis J, Hylarides MD, Leon AA: Endotoxin provocation of experimental renal cystic disease. Kidney Int. 1987, 32 (3): 329-334. 10.1038/ki.1987.213.CrossRefPubMed Gardner KD, Reed WP, Evan AP, Zedalis J, Hylarides MD, Leon AA: Endotoxin provocation of experimental renal cystic disease. Kidney Int. 1987, 32 (3): 329-334. 10.1038/ki.1987.213.CrossRefPubMed
31.
go back to reference Pirson Y: Does TNF-alpha enhance cystogenesis in ADPKD?. Nephrol Dial Transplant. 2008, 23 (12): 3773-3775. 10.1093/ndt/gfn533.CrossRefPubMed Pirson Y: Does TNF-alpha enhance cystogenesis in ADPKD?. Nephrol Dial Transplant. 2008, 23 (12): 3773-3775. 10.1093/ndt/gfn533.CrossRefPubMed
32.
go back to reference Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, Mayeux PR: Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol. 2007, 292 (1): F261-F268.CrossRefPubMed Wu L, Tiwari MM, Messer KJ, Holthoff JH, Gokden N, Brock RW, Mayeux PR: Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice. Am J Physiol Renal Physiol. 2007, 292 (1): F261-F268.CrossRefPubMed
33.
go back to reference Chapman AB, Guay-Woodford LM: Renal volume in children with ADPKD: size matters. Clin J Am Soc Nephrol. 2009, 4 (4): 698-699. 10.2215/CJN.01410209.CrossRefPubMed Chapman AB, Guay-Woodford LM: Renal volume in children with ADPKD: size matters. Clin J Am Soc Nephrol. 2009, 4 (4): 698-699. 10.2215/CJN.01410209.CrossRefPubMed
34.
go back to reference Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, et al: Volume progression in polycystic kidney disease. N Engl J Med. 2006, 354 (20): 2122-2130. 10.1056/NEJMoa054341.CrossRefPubMed Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, et al: Volume progression in polycystic kidney disease. N Engl J Med. 2006, 354 (20): 2122-2130. 10.1056/NEJMoa054341.CrossRefPubMed
Metadata
Title
Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease
Authors
Jin Ho Hwang
Hayne Cho Park
Jong Cheol Jeong
Seon ha Baek
Mi Yeun Han
Kitae Bang
Jeong Yeon Cho
Suk Hee Yu
Jaeseok Yang
Kook-Hwan Oh
Young-Hwan Hwang
Curie Ahn
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-1

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.